The core principle of BETMAT’s Kinetic Chromogenic LAL Assay is based on the specific enzymatic cascade triggered by the interaction between Limulus Amebocyte Lysate (LAL) and bacterial ...

Hit identification and hit validation represent distinct but connected stages of early drug discovery. This article examines ...

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...

May 5, 2026, 5 p.m. ET President and Chief Executive Officer — Brian J. Blaser Chief Financial Officer — Joseph M. Busky Vice ...

Viralgen continues its pioneering work in manufacturing science with advancements in key process understanding with analytical tools ...

Autonomous and automated laboratory systems are rapidly transforming the landscape of drug discovery by combining robotics, advanced sensing, and ...

Equity-Insider.com News Commentary ? The gold sector just posted a striking contradiction. Exploration budgets climbed 11% to US$6.2 billion last year, now accounting for half of all global mining ...

Natera, Inc. ( NTRA) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT Ladies and gentlemen, welcome to Natera's First Quarter 2026 Financial Results Conference Call. As a reminder, this conference call ...

Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...

Izicopan is an investigational next-generation oral C5aR1 inhibitor designed to achieve differentiated pharmacological properties, with the potential for improved efficacy and safety. The marketed ...

Xencor (NASDAQ:XNCR) used a webcast during Digestive Disease Week 2026 to highlight Phase I results for its TL1A-targeting ...

Detailed price information for Lion One Metals Limited (LIO-X) from The Globe and Mail including charting and trades.